Medicare Enrolled

Dr. Kandan Kulandaivel, M.D.

Neurology · Abington, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1151 OLD YORK RD STE 200, Abington, PA 19001
2159579250
In practice since 2008 (18 years)
NPI: 1104089119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kulandaivel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kulandaivel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kulandaivel

Dr. Kandan Kulandaivel is a neurology specialist in Abington, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kulandaivel performed 645 Medicare services across 547 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kulandaivel received a total of $15,948 from 67 pharmaceutical and/or device companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kulandaivel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 21% volume in PA $15,948 industry payments

Medicare Practice Summary

Medicare Utilization ↗
645
Medicare services
Top 21% in PA for neurology
547
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
230 $100 $260
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
93 $137 $301
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
79 $109 $328
New patient office visit, complex (60-74 min) 69 $176 $414
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
51 $46 $157
Video EEG monitoring, 12-26 hours
A 12 to 26-hour test that records brain wave activity while simultaneously capturing video of the patient's behavior.
28 $828 $1,500
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $71 $147
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
19 $207 $500
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
19 $60 $191
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
17 $341 $1,420
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
13 $145 $491
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,948
Total received (2018-2024)
Avg $2,278/year across 7 years
Top 17% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
403
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,804 (61.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,372 (33.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$772 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,026
2023
$6,244
2022
$3,773
2021
$708
2020
$960
2019
$1,851
2018
$1,385

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$267
ARGENX US, INC.
$166
Celgene Corporation
$164
SK Life Science, Inc.
$70
Lundbeck LLC
$63
Merz Pharmaceuticals, LLC
$39
Alexion Pharmaceuticals, Inc.
$39
CSL Behring
$27
AstraZeneca Pharmaceuticals LP
$25
MDD US Operations, LLC
$23
Ipsen Biopharmaceuticals, Inc
$21
GENZYME CORPORATION
$20
Teva Pharmaceuticals USA, Inc.
$20
Genentech USA, Inc.
$19
Axsome Therapeutics, Inc.
$17
Grifols USA, LLC
$17
Sumitomo Pharma America, Inc.
$16
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$3,768
UCB, Inc.
$2,209
Celgene Corporation
$1,454
ABBVIE INC.
$1,249
LivaNova USA, Inc.
$784
Alexion Pharmaceuticals, Inc.
$598
Supernus Pharmaceuticals, Inc.
$468
Sunovion Pharmaceuticals Inc.
$377
SK Life Science, Inc.
$376
ARGENX US, INC.
$351
GENZYME CORPORATION
$310
EMD Serono, Inc.
$248
Novartis Pharmaceuticals Corporation
$226
Lundbeck LLC
$222
UPSHER-SMITH LABORATORIES LLC
$216
Biogen, Inc.
$189
Eisai Inc.
$185
Sumitomo Pharma America, Inc.
$174
CSL Behring
$152
Amgen Inc.
$145
Janssen Pharmaceuticals, Inc
$136
EISAI INC.
$136
Sanara MedTech Inc.
$133
Teva Pharmaceuticals USA, Inc.
$131
Akcea Therapeutics, Inc.
$120
Neurelis, Inc.
$116
AbbVie Inc.
$99
Avanir Pharmaceuticals, Inc.
$77
MDD US Operations, LLC
$75
Merz Pharmaceuticals, LLC
$67
Biohaven Pharmaceuticals, Inc.
$66
JAZZ PHARMACEUTICALS INC.
$62
Genentech USA, Inc.
$59
Harmony Biosciences LLC
$58
HARMONY BIOSCIENCES LLC
$54
Avion Pharmaceuticals
$53
Greenwich Biosciences, Inc.
$46
Lilly USA, LLC
$43
Biohaven Pharmaceutical Holding Company Ltd.
$42
TG THERAPEUTICS, INC.
$38
Jazz Pharmaceuticals Inc.
$37
Ipsen Biopharmaceuticals, Inc
$36
Acorda Therapeutics, Inc
$36
Amneal Pharmaceuticals LLC
$35
Grifols USA, LLC
$34
Impax Laboratories, Inc.
$31
Scilex Pharmaceuticals Inc.
$30
Upsher-Smith Laboratories LLC
$27
Vertical Pharmaceuticals, LLC
$26
AstraZeneca Pharmaceuticals LP
$25
Hoffmann-La Roche Limited
$25
Corium, LLC
$24
Mallinckrodt Enterprises LLC
$24
Abbott Laboratories
$24
IMPEL PHARMACEUTICALS INC.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
PFIZER INC.
$19
Alnylam Pharmaceuticals Inc.
$19
BOSTON SCIENTIFIC CORPORATION
$18
Axsome Therapeutics, Inc.
$17
CATALYST PHARMACEUTICALS, INC.
$17
PORTOLA PHARMACEUTICALS, INC.
$17
AQUESTIVE THERAPEUTICS, INC.
$15
GE HealthCare
$15
Merck Sharp & Dohme Corporation
$14
Azurity Pharmaceuticals, Inc.
$14
Mylan Pharmaceuticals Inc.
$13
Top 3 companies account for 46.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Adlarity · Aimovig · BEVYXXA · BOTOX · BRIUMVI · Betaseron · Briviact · CellerateRx · DYSPORT · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · HORIZANT · Hizentra · INBRIJA · INFINITY · JANUVIA · KYNMOBI · LEMTRADA · LORZONE · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NURTEC ODT · Neupro · OCREVUS · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · Ponvory · QULIPTA · RELEXXII · REXULTI · RYTARY · Rebif · SOLIRIS · SYMPAZAN · Soliris · Sunosi · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · Wakix · XCOPRI · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Abington?
Compare neurologists in the Abington area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
530
Per 100K population
61.5
County median income
$111,521
Nearest hospital
JEFFERSON ABINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kulandaivel is a clinical cardiology specialist, with above-average Medicare volume (top 21% in PA), with low-engagement industry engagement in the top 17% of PA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kulandaivel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kulandaivel performed 230 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kulandaivel receive payments from pharmaceutical companies?
Yes. Dr. Kulandaivel received a total of $15,948 from 67 companies across 403 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kulandaivel's costs compare to other neurologists in Abington?
Dr. Kulandaivel's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kulandaivel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →